For patients facing terminal illness who have exhausted approved treatment options, the traditional pathway to accessing new therapies—enrolling in clinical trials—may be unavailable or impractical. Geographic distance, strict eligibility criteria, advanced disease state, or simply the randomization … [Read more...]